<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04768439</url>
  </required_header>
  <id_info>
    <org_study_id>00007555-00015712</org_study_id>
    <nct_id>NCT04768439</nct_id>
  </id_info>
  <brief_title>Low and High Doses of Prophylactic Vitamin D in Prevention of Osteopenia of Prematurity</brief_title>
  <official_title>Comparison Between Low and High Doses of Prophylactic Vitamin D in Prevention of Osteopenia of Prematurity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the effects of low and high doses of prophylactic vitamin D on biochemical and&#xD;
      radiological manifestations of osetopenia of prematurity will be tested.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be conducted on (80) preterm infants that fulfill the eligibility criteria and&#xD;
      delivered at Alexandria University Maternity Hospital (AUMH).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 10, 2020</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 20, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Calcium level and activity</measure>
    <time_frame>six weeks</time_frame>
    <description>Serum calcium level will be measured and analyzed using Advia 1800 chemistry system (Simens Germany). Normal level: 8.5 to 10.5 mg/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Phosphorus level and activity</measure>
    <time_frame>six weeks</time_frame>
    <description>Serum phosphorus level will be measured and analyzed using Advia 1800 chemistry system (Simens Germany). Normal level: 3.4 to 4.5 mg/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alkaline phosphatase level and activity</measure>
    <time_frame>six weeks</time_frame>
    <description>Serum alkaline phosphate level will be measured and analyzed using Advia 1800 chemistry system (Simens Germany). Normal level: 50-100 U/L.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>25-Hydroxy Vitamin D</measure>
    <time_frame>six weeks</time_frame>
    <description>Serum 25-Hydroxy Vitamin D level will be measured and analyzed using Electrochemilumiescence binding assay on cobas e immunoassay analyzer. The reference range of the total 25(OH)D level is 25-80 ng/mL.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone fracture</measure>
    <time_frame>six weeks</time_frame>
    <description>This will be evaluated using an x-ray of left wrist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intracortical resorption</measure>
    <time_frame>six weeks</time_frame>
    <description>This will be evaluated using an x-ray of left wrist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Losing the sharp bone border (fraying)</measure>
    <time_frame>six weeks</time_frame>
    <description>This will be evaluated using an x-ray of left wrist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cupping of metaphyseal edge of bone</measure>
    <time_frame>six weeks</time_frame>
    <description>This will be evaluated using an x-ray of left wrist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Widening of the distal end of the metaphysis of bone</measure>
    <time_frame>six weeks</time_frame>
    <description>This will be evaluated using an x-ray of left wrist</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Osteopenia of Prematurity</condition>
  <arm_group>
    <arm_group_label>200 IU/d vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive low-dose vitamin D (200 IU/d)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1600 IU/d vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive high-dose vitamin D (1600 IU/d)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low Dose Vitamin D</intervention_name>
    <description>Patients will receive a 200 IU/d vitamin D since they tolerate full enteral nutrition.</description>
    <arm_group_label>200 IU/d vitamin D</arm_group_label>
    <other_name>1,25-Dihydroxycholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High Dose Vitamin D</intervention_name>
    <description>Patients will receive 1600 IU/d vitamin D since they tolerate full enteral nutrition.</description>
    <arm_group_label>1600 IU/d vitamin D</arm_group_label>
    <other_name>1,25-Dihydroxycholecalciferol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Newborns with gestational age of ≤ 32 weeks and birth weight ≤ 1500 g.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Newborns whose mothers were taking specific medications interacting with vitamin D&#xD;
             metabolism (e.g., anticonvulsants, diuretics)&#xD;
&#xD;
          -  Being NPO (nothing per oral) for more than 2 wks&#xD;
&#xD;
          -  Gestational age more than 32 weeks&#xD;
&#xD;
          -  Birth weight more than 1500 grams&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marwa M Farrag, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Alexandria University, Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.</name>
      <address>
        <city>Alexandria</city>
        <zip>21131</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 21, 2021</study_first_submitted>
  <study_first_submitted_qc>February 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2021</study_first_posted>
  <last_update_submitted>September 11, 2021</last_update_submitted>
  <last_update_submitted_qc>September 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Marwa Mohamed Farag</investigator_full_name>
    <investigator_title>Lecturer in Pediatrics, Faculty of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Dihydroxycholecalciferols</mesh_term>
    <mesh_term>Calcitriol</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

